Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability

Journal Article · · ACS Med. Chem. Lett.
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; more »; ; ; ; ; « less

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; INDUSTRY
OSTI ID:
1832590
Journal Information:
ACS Med. Chem. Lett., Vol. 12, Issue (9)
Country of Publication:
United States
Language:
ENGLISH

References (38)

Emerging Opportunities and Challenges in Cancer Immunotherapy April 2016
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy August 2018
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors November 2018
Comprehensive analysis of the clinical immuno-oncology landscape January 2018
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies March 2018
R EGULATION OF E NZYMES OF THE U REA C YCLE AND A RGININE M ETABOLISM July 2002
Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment April 2015
Arginase: an emerging key player in the mammalian immune system: Arginase in the immune system September 2009
Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses August 2004
Arginase in patients with breast cancer February 2003
Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion April 2005
Elevated Serum Arginase Activity Levels in Patients with Breast Cancer September 2003
Serum Arginase Level in Patients with Gastric Cancer January 1994
Research of novel anticancer agents targeting arginase inhibition April 2018
Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment December 2017
Boronic acid-based arginase inhibitors in cancer immunotherapy September 2020
Arginase Inhibitors: A Rational Approach Over One Century: AN EXHAUSTIVE REVIEW OF ARGINASE INHIBITORS November 2016
Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors October 2016
Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158 January 2020
Discovery of ( R )-2-Amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic Acid and Congeners As Highly Potent Inhibitors of Human Arginases I and II for Treatment of Myocardial Reperfusion Injury March 2013
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy March 2020
Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response September 2005
A Spectrophotometric Assay of Arginase August 2001
Development of a Zinc-Mediated Approach to a 2,3- cis -Pyrrolidine Arginase Inhibitor June 2020
Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors March 2020
The role of ligand efficiency metrics in drug discovery January 2014
Photo-induced Substitutive Introduction of the Aldoxime Functional Group to Carbon Chains: A Formal Formylation of Non-Acidic C(sp 3 )−H Bonds June 2016
trans-3-n-propyl-L-proline is a highly favorable, conformationally restricted replacement for methionine in the C-terminal tetrapeptide of cholecystokinin. Stereoselective synthesis of 3-allyl- and 3-n-propyl-L-proline derivatives from 4-hydroxy-L-proline January 1991
Synthesis and evaluation of new ω-borono-α-amino acids as rat liver arginase inhibitors April 2005
Binding of α,α-Disubstituted Amino Acids to Arginase Suggests New Avenues for Inhibitor Design August 2011
2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitors April 2013
Synthesis of quaternary α-amino acid-based arginase inhibitors via the Ugi reaction September 2013
Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods:  An Analysis of ALOGP and CLOGP Methods May 1998
The Critical Role of Passive Permeability in Designing Successful Drugs September 2020
Targeting Intestinal Transporters for Optimizing Oral Drug Absorption November 2010
Efficient method for inversion of secondary alcohols by reaction of chloromethanesulfonates with cesium acetate August 1996
Discovery of indoximod prodrugs and characterization of clinical candidate NLG802 July 2020
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy September 2019

Similar Records

Related Subjects